References

• Keisner SV, Shah SR. Pazopanib. Drugs. 2011;71(4):443-454. google scholar
• Schutz FA, Choueiri TK, Sternberg CN. Pazopanib: Clinical development of a potent anti-angiogenic drug. Crit Rev Oncol Hematol. 2011;77(3):163-171. google scholar
• Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res. 2000;55:15-35. google scholar
• Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27:563-584. google scholar
• Ustun E, Sahin N. Analysis of interactions of NHC type molecules and NHC-Ag complexes with VEGFR-2 and DNA: A molecular docking study. Adiyaman Univ J Sci. 2021;11(1):113-125. google scholar
• İvy SP, Wick JY, Kaufman BM. An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol. 2009;6(10):569-579. google scholar
• Jayaraman S, Umapathy VR, Govindaraj J, Govidaraj K. Molecular docking analysis of vascular endothelial growth factor receptor with bioactive molecules from Piper longum as potential anti-cancer agents. Bioinformation. 2021;17(1):223-228. google scholar
• Demirtas B. Küçük hücreli olmayan akciğer kanseri hücre hattında (a549) yeni bir tirozin kinaz inhibitörü olan Pazopanibin (gw786034) antianjiyojenik etkilerinin araştırılması, 2013, Yüksek Lisans Tezi, Anadolu Üniversitesi. google scholar
• Soylemez CM. Pazopanib tedavisi alan metastatik yumuşak doku sarkomu hastalarında tedavi yanıtı ve bu durumu etkileyen faktörler, retrospektif analizi, 2021, Uzmanlık tezi, Ege Üniversitesi. google scholar
• Van Der Graaf WT, Blay JY, Chawla SP, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2012;379(9829):1879-1886. google scholar
• Lee AT, Jones RL, Huang PH. Pazopanib in advanced soft tissue sarcomas. Signal Transduct Target Ther. 2019;4(1):1-10. google scholar
• Ferlay J, Soerjomataram İ, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386. google scholar
• Sternberg CN, Davis İD, Mardiak J, et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: Results of a randomized phase İİİ trial. J Clin Oncol. 2010;28(6):1061-1068. google scholar
• Li W, Feng C, Di W, et al. Clinical use of vascular endothelial growth factor receptor inhibitors for the treatment of renal cell carcinoma. Eur J Med Chem. 2020;200:112482. doi:10.1016/j.ejmech.2020.112482 google scholar
• Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016;17(10):611-625. google scholar
• Tzima E, Irani-Tehrani M, Kiosses, et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 2005;437(7057):426-431. google scholar
• Hurwitz HI, Dowlati A, Saini S, et al. Phase I trial of Pazopanib in patients with advanced cancer. Clin Cancer Res. 2009;15(12):4220-4227. google scholar
• Pedretti A, Villa L, Vistoli G. VEGA: A versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model. 2002;21(1):47-49. google scholar
• Pedretti A, Villa L, Vistoli G. Atom-type description language: A universal language to recognize atom types implemented in the VEGA program. Theor. Chem. Acc. 2003;109(4):229-232. google scholar
• Pedretti A, Villa L, Vistoli G. VEGA-an öpen platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. J Comput Aided Mol Des. 2004;18(3):167-173. google scholar
• Jurcik A, Bednar D, Byska J, et al. CAVER Analyst 2.0: Analysis and visualization of channels and tunnels in protein structures and molecular dynamics trajectories. Bioinformatics. 2018;34(20):3586-3588. google scholar
• Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-461. google scholar
• Krieger E, Vriend G. YASARA View—molecular graphics for all devices—from smartphones to workstations. Bioinformatics. 2014;30(20):2981-2982. google scholar
• Maier JA, Martinez C, Kasavajhala K, et al. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11(8):3696-3713. google scholar
• Jakalian A, Jack DB, Bayly Cl. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem. 2002;23(16):1623-1641. google scholar
• Meyer M, Pontikis V. Computer simulation in materials science: Interatomic potentials, simulation techniques and applications, Springer Science & Business Media; 2012. google scholar
• Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys. 1995;103(19):8577-8593. google scholar
• Dlala NA, Bouazizi Y, Ghalla H, Hamdi N. DFT calculations and molecular docking studies on a chromene derivative. J Chem. 2021;2021(1):6674261. doi:10.1155/2021/6674261 google scholar
• Borkakoti N, Palmer RA. The structure of the bisbenzylisoquinoline alkaloid methylwarifteine. Acta Crystallogr. B. 1978;34(2):490-495. google scholar
• Cox EG. Crystal structure of benzene. Rev Mod Phys. 1958;30(1):159. doi:10.1103/ RevModPhys.30.159 google scholar
• Sloan B, Scheinfeld NS. Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy. Curr. Opin. Investig. Drugs. 2008;9(12):1324-1335. google scholar
• Cubukcu E, Birol, O. Altmışbeş yaş üstü metastatik yumuşak doku sarkom hastalarında pazopanib tedavisinin etkinliğinin retrospektif değerlendirilmesi. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2019;45(1):83-86. google scholar
• Schutz FA, Choueiri TK, Sternberg CN. Pazopanib: Clinical development of a potent anti-angiogenic drug. Crit Rev Oncol Hematol. 2011;77(3):163-171. google scholar
• Sleijfer S, van der Graaf WT, Blay JY. Angiogenesis inhibition in non-GIST soft tissue sarcomas. The Oncologist. 2008;13(11):1193-1200. google scholar
• DuBois S, Demetri G. Markers of angiogenesis and clinical features in patients with sarcoma. Cancer. 2007;109(5):813-819. google scholar
• Tresaugues L, Roos A, Arrowsmith C, et al. Crystal structure of VEGFR1 in complex with N-(4-Chlorophenyl)-2-((pyridin-4-ylmethyl) amino) benzamide. 2013. doi: 10.2210/pdb3hng/pdb google scholar
• Oguro Y, Miyamoto N, Okada K, et al. Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo [3, 2-d] pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation. Bioorg Med Chem. 2010;18(20):7260-7273. google scholar
• Wang Z, Wang X., Li Y., et al. farPPI: A webserver for accurate prediction of protein-ligand binding structures for small-molecule PPI inhibitors by MM/PB (GB) SA methods. Bioinformatics. 2019;35(10):1777-1779. google scholar
• Hao GF, Jiang W, Ye YN, et al. ACFIS: A web server for fragment-based drug discovery. Nucleic Acids Res. 2016;44(W1):W550-W556. google scholar
• Hao GF, Wang F, Li H, et al. Computational discovery of picomolar Q o site inhibitors of cytochrome bc 1 complex. J Am Chem Soc. 2012;134(27):11168-11176. google scholar
• Yang JF, Wang F, Jiang W, et al. PADFrag: A database built for the exploration of bioactive fragment space for drug discovery. J Chem Inf Model. 2018;58(9):1725-1730. google scholar
• Cheron N, Jasty N, Shakhnovich EI. OpenGrowth: An automated and rational algorithm for finding new protein ligands. J Med Chem. 2016;59(9):4171-4188. google scholar
• Wang E, Sun H, Wang J, et al. End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design. Chem Rev. 2019;119(16):9478-9508. google scholar
• Pogodin PV, Lagunin AA, Rudik AV, et al. AntiBac-Pred: A web application for predicting antibacterial activity of chemical compounds. J Chem Inf Model. 2019;59(11):4513-4518. google scholar
• Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature. 2016;529(7586):336-343. google scholar
• Gaulton A, Hersey A, Nowotka M, et al. The ChEMBL database in 2017. Nucleic Acids Res. 2017;45(D1):D945-D954. google scholar
• Fourches D, Muratov E, Tropsha A. Curation of chemogenomics data. Nat Chem Biol. 2015;11(8):535-535. google scholar
• Pogodin PV, Lagunin AA, Filimonov DA, Poroikov VV. PASS Targets: Ligand-based multi-target computational system based on a public data and naıve Bayes approach. SAR QSAR Environ Res. 2015;26(10):783-793. google scholar
• Pogodin PV, Lagunin AA, Rudik AV, et al. How to achieve better results using PASS-Based virtual screening: Case study for kinase inhibitors. Front Chem. 2018;6(133):1-14. google scholar
• Filimonov DA, Lagunin AA, Gloriozova TA, et al. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem Heterocycl Compd. 2014;50(3):444-457. google scholar
• Zaidi Z, Sharma G, Sahaya Shibu B, et al. In silco prediction of pharmacological properties of the 2-(4-allylpiperazin-1-yl)-1-(1-(4-nitrophenyl)-1h-tetrazol-5-yl) ethanone. Afr J Biol Sci. 2024;6:2522-2540. google scholar
• Cadow J, Born J, Manica M, Oskooei A, Rodrıguez Martinez M. PaccMann: A web service for interpretable anticancer compound sensitivity prediction. Nucleic Acids Res. 2020;48(W1):W502-W508. google scholar
• Kuzu B, Karakuş F. Natural compounds targeting VEGFRs in kidney cancer: An in silico prediction. JIST. 2022;12(3):1711-1722. google scholar
• Bharathi D, Boopathy RA. In silico studies on colon cancer against hexadecane, hexadecanoic acid methyl ester and quinoline, 1, 2-dihydro-2, 2, 4-trimethyl compounds from brown seaweed. IJRPS. 2020;11(2):1927-1935. google scholar
• Kouassi K, Ganiyou A, Didier D, Benie A, Nahosse Z. In silico docking of rhodanine derivatives and 3D-QSAR study to identify potent prostate cancer inhibitors. Comput Chem. 2022;10(2):19-52. google scholar
• Mendie LE, Hemalatha S. Molecular docking of phytochemicals targeting GFRs as therapeutic sites for cancer: An in silico study. Appl Biochem Biotechnol. 2022;194(1):215-231. google scholar
• Lu SL, Noda T. VEGF (vascular endothelial growth factor) provides antimicrobial effects via autophagy and lysosomal empowerment in endothelial cells. Autophagy Reports. 2022;1(1):555-558. google scholar
• Amiri-Kordestani L, Tan AR, Swain SM. Pazopanib for the treatment of breast cancer. Expert Opin Investig Drugs. 2012;21(2):217-225. google scholar
• Zhao H,Yang F, Shen W, et al. Pazopanib diminishes non-small celi lung cancer (NSCLC) growth and metastases in vivo. Thorac Cancer. 2015;6(2):133-140. google scholar
• Roberts JL, Tavallai M, Nourbakhsh A, et al. GRP78/Dna K is a target for Nexavar/ Stivarga/Votrient in the treatment of human malignancies, viral infections and bacterial diseases. J Cell Physiol. 2015;230(10):2552-2578. google scholar
• Kaur N, Aggarwal AK, Sharma N, Choudhary B. Synthesis and in-vitro antimicrobial activity of pyrimidine derivatives. Int J Pharm Sci Drug Res. 2012;4(3):199-204. google scholar
• Abdel-Mohsen HT, Ragab FA, Ramla MM, El Diwani Hl. Novel benzimidazole-pyrimidine conjugates as potent antitumor agents. Eur J Med Chem. 2010;45(6):2336-2344. google scholar
• Sirisoma N, Kasibhatla S, Nguyen B, et al. Discovery of substituted 4-anilino-2-(2-pyridyl) pyrimidines as a new series of apoptosis inducers using a cell-and caspase-based high throughput screening assay. Part 1: Structure-activity relationships of the 4-anilino group. Bioorg Med Chem. 2006;14(23):7761-7773. google scholar
• Xie F, Zhao H, Zhao L, Lou L, Hu Y. Synthesis and biological evaluation of novel 2, 4, 5-substituted pyrimidine derivatives for anticancer activity. Bioorg Med Chem Lett. 2009;19(1):275-278. google scholar
• Kamal A, Dastagiri D, Ramaiah MJ, et al. Synthesis and apoptosis inducing ability of new anilino substituted pyrimidine sulfonamides as potential anticancer agents. Eur J Med Chem. 2011;46(12):5817-5824. google scholar
• Pontikis R, Benhida R, Aubertin AM, Grierson DS, Monneret C. Synthesis and anti-HIV activity of novel N-1 side chain-modified analogs of 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT). J Med Chem. 1997;40(12):1845-1854. google scholar
• Lu X, Chen Y, Guo Y, et al. The design and synthesis of N-1-alkylated-5-aminoaryalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors. Bioorg Med Chem. 2007;15(23):7399-7407. google scholar
• Das K, Clark Jr. AD, Lewi PJ, et al. Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. J Med Chem. 2004;47(10):2550-2560. google scholar
• Summa V, Petrocchi A, Bonelli F, et al. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. J Med Chem. 2008;51:5843-5855. google scholar
• Tagat JR, McCombie SW, Nazareno D, et al. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV.Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]-4-methylpipe ridine(Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist. J Med Chem. 2004;47:2405-2408. google scholar
• Huckova D, Holy A, Masojidkova M, et al. Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds. Bioorg Med Chem. 2004;12(12):3197-3202. google scholar
• Deshmukh MB, Salunkhe SM, Patil DR, Anbhule PV. A novel and efficient one step synthesis of 2-amino-5-cyano-6-hydroxy-4-arylpyrimidines and their anti bacterial activity. Eur J Med Chem. 2009;44:2651-2654. google scholar
• Roth B, Strelitz JZ, Rauckman BS. 2,4-Diamino-5-benzylpyrimidines and analogs as antibacterial agents.2.C-Alkylation of pyrimidines with Mannich bases and application to the synthesis of trimethoprim and analogs. J Med Chem. 1980;23(3):379-384. google scholar
• Chandrashekaran S, Nagarajan S. Microwave-assisted synthesis and anti-bacterial activity of some 2-Amino-6-aryl-4-(2-thienyl) pyrimidines. IL Farmaco. 2005;60:279-282. google scholar
• Mai A, Rotili D, Massa S, et al. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans. Bioorg Med Chem Lett. 2007;17:1221-1225. google scholar
• Gholap AR, Toti KS, Shirazi F, Deshpande MV, Srinivasan KV. Efficient synthesis of antifungal pyrimidines via Palladium catalyzed Suzuki/Sonogashira cross-coupling reaction from Biginelli 3,4-dihydropyrimidin-2(1H)-ones. Tetrahedron. 2008;64:10214-10223. google scholar
• Ingaral N, Saravanan G, Amutha P, Nagarajan S. Synthesis, in vitro antibacterial and antifungal evaluations of 2-amino-4-(1-naphthyl)-6-arylpyrimidines. Eur J Med Chem. 2007;42:517-520. google scholar

Citations